studied MSS and illustrates many of the methodological issues. This 30-item questionnaire, assessing time, place, registration and recall, attention and calculation, language and parietal skills,3 is unique in that it is well established on both sides of
The stethoscope was the most significant addition to clinical examination in the last century. Brief mental status schedules (also known as mental test scores) to examine cognitive function may represent the most significant innovation of this century for those looking after the largest subpopulation of health-care users, the elderly. In this group, clinically significant cognitive impairment is common, and intact social skills may disguise the deficit at a superficial interaction with a physician. Despite its importance, the measurement of cognitive function has been a relatively neglected domain for non-psychiatrists, with few helpful anamnestic aids apart from the formula of 'oriented in time, person and place'. Cognitive function can now be graded by clinicians in a simple way with a short questionnaire: many scores have cut-off points below which cognitive impairment is probable. In some forms of mental status schedules (MSS), individual areas of decline in higher function can be pinpointed. Cognitive impairment is not pathognomic of conditions such as dementia or delirium but is suggestive of their presence, in the same way that crepitations on chest examination may indicate various forms of cardiopulmonary disease. Just as the diagnosis of pneumonia or congestive cardiac failure is not made by auscultation alone, a poor score on an MSS must be considered in conjunction with the rest of the history and examination. Indeed, the sensitivity and specificity of auscultation in the elderly' is probably less than that of many MSSs.
Simple clinical technology often has a sophisticated methodology: the first book in the English language on the use of the stethoscope was 226 pages long.2 Similarly, there is a significant literature on the selection and application of MSSs. The choice of an MSS is complicated by the existence of over 40 simple instruments, analogous to early medical catalogues which described up to 25 types of stethoscopes. A further complication is that some MSSs sport multiple versions. For example, four versions of the Folstein Mini-Mental State Examination (MMSE)>-6 and three of the Kew test7-9 have been described in the United Kingdom alone. Rational selection and choice of cut-off points depend on the setting in which the MSS is administered, precise methodology, suitable validation studies, attention to the effects of education and race, and the time needed to complete the test. This is true for the main groups who use the MSS for different purposes: clinicians, researchers and epidemiologists.
The setting in which an MSS is used is important for three reasons. The first is that the prevalence of illnesses causing cognitive impairment is higher in institutions and hospitals than in communitydwelling elderly people. This alters the clinical significance of published sensitivities and specificities. Secondly, most MSSs have been designed and validated in institutional settings, and often contain questions that relate to this environment. For example, one group of MSSs asks the patient to recognize two people, a question of limited utility in the home of an elderly person living alone.'0-12 Such questionnaires need alteration and revalidation of their cut-off points to be of use in the community. The setting is also important because patients perform better in their own environment, by a margin of five points or more in 25% of cases with the MMSE. 13 A very important (if less scientific!) consideration is that of time. IfMSSs are to be used widely by busy physicians, they need to be as briefas possible. If the 5-10 minutes required for instruments such as the MMSE is considered too lengthy, time might be economized by using a shorter score. The compromise engendered by the shortest tests (about ten questions) is that they suffer from a more pronounced 'ceiling' effect whereby many patients with mild cognitive impairment may score no errors.6 Therefore those clinicians who feel that the MMSE is too lengthy for routine use might consider using a hierarchical approach, with a short MSS as a first-line instrument and the MMSE as a complementary test when there is concern about the possibility of cognitive impairment.
The measurement of longitudinal change in cognitive function is one aspect of MSS where the analogy with a stethoscope falls short. It is difficult to change an auscultatory examination by preparation. Although MSS have proved useful in research studies of changes in cognitive function,3' this may not be the case if they are used routinely: patients may become familiar with the questions and try to prepare for the administration of schedules.32 Many longer psychological tests have alternative forms to compensate for learning effects: this is not yet a feature of MSS. Only relatively large changes can be measured reliably and threshold effects may mask change. Therefore the relevance of modest changes to the clinician, as opposed to the researcher, is uncertain.
The methodology of MSSs is becoming more clear. If used appropriately, they are an effective and relevant clinical tool. The main danger is not to relate the score to the overall history, examination and functional assessment. As an MSS screens for a state, cognitive impairment, and not directly for specific diseases, a positive result requires further evaluation. Accepted criteria for dementia and delirium33 provide a useful template for clinical decision-making. In case of doubt, longitudinal assessment34 or referral for specialist advice is preferable to a precipitate diagnosis of dementia.
